Msd Partners, L.P. Oragenics Inc Transaction History

Msd Partners, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$0.78 - $3.57 $33,196 - $151,935	-42,559 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.16 - $2.0 $49,368 - $85,118	42,559 New	42,559 $59,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $34.9M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Msd Partners, L.P. with notifications on news.